Skip to main content
Clinical Trials/JPRN-UMIN000004950
JPRN-UMIN000004950
Recruiting
未知

Acute aspirin plus cilostazol Dual Therapy for non-cardioembolic stroke patients within 48 h of symptom onset -a prospective, multicenter, randomized, an aspirin-controlled study- - Acute aspirin plus cilostazol Dual Therapy for non-cardioembolis stroke

Stroke Medicine Kawasaki Medical School0 sites2,000 target enrollmentJune 2, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
on cardioembolic stroke
Sponsor
Stroke Medicine Kawasaki Medical School
Enrollment
2000
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 2, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Stroke Medicine Kawasaki Medical School

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • cardioembolic stroke preadmission antithrombotic therapy (cilostazol, aspirin 200mg or over, clopidgrel, ticlopidine, anticoagulants) congestive heart failure pregnancy allergy

Outcomes

Primary Outcomes

Not specified

Similar Trials